IFNG and neoplasm: A preclinical study of B-cell lymphoma suggested that IL-12-secreting CD19 CAR T cells increased their IFN-γ production and could eradicate tumor cells without the need for depleting chemotherapy through the recruitment of host immune cells [34] (Figure 2b).